This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

June 22-24, 2021
Delivered in a 100% Virtual FormatPacific Standard Time (PST)

June 22-24, 2021
Delivered in a 100% Virtual Format,
Pacific Standard Time (PST)

CAR AND T CELL THERAPIES: IMPROVE THE SAFETY & EFFICACY OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA

Revolutionizing cell and gene engineering - ground breaking autologous and allogeneic treatments for blood borne and solid tumors

EVENT UPDATE:

The virtual event platform is now open for networking and login details were sent on June 15. If you are a registered attendee and require instructions on how to login please click here.

Novel Technological Advances & Applications to help you Revolutionize Early Phase Development


Next Generation Solid Tumour Approaches
Next Generation Solid Tumour Approaches
  • Understand novel combination approaches to improve efficacy in solid tumours
  • Get to grips with the identification of new targets for the treatment of broad patient populations
  • Hear the latest on engineering techniques to improve mechanism of action
Is the Future Allogeneic? CARNK, iPSc and Future Considerations
Is the Future Allogeneic? CARNK, iPSc and Future Considerations
  • Benchmark with key companies discussing current trends and successes seen here
  • Join the debate around the future of CART and if allogeneic will replace autologous therapies
  • Have your say on the use of allogeneic treatments for solid and hematological malignancies
Novel CAR and T Cell Modalities – Safety, Efficacy and Clinical Data
Novel CAR and T Cell Modalities – Safety, Efficacy and Clinical Data
  • Stay abreast of the latest clinical data for CAR-NK, CAR-Macrophage, Modified TILs and more…
  • Revolutionize how novel CARs and TCRs are being explored
  • Create a feedback loop between clinical trials and translational science for product improvement

Take a Virtual Tour of Next Generation CAR & T Cell Therapies 2021


Our best-in-class virtual platform makes it easier than ever for you to access today's leading science, technologies and networking opportunities within the global CAR & T Cell Therapies community.

CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2021 VIRTUALLY

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)7717 508900